Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients
Launched by ZEALAND UNIVERSITY HOSPITAL · Nov 14, 2019
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
Fit for surgery is a randomized clinical trial of multimodal prehabilitation prior to colon or rectal cancer surgery. Participants will either receive
The study is a part of the PREHAB study which is performed in collaboration with international centers.
The full protocol are published BMC Cancer. 2019 Jan 22;19(1):98. doi: 10.1186/s12885-018-5232-6.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing elective colorectal cancer surgery
- • WHO performance status I and II
- • Signed consent
- Exclusion Criteria:
- • Known metastatic disease
- • Unable to perform baseline test or basic training e.g. paralytic or completely immobilized patients, orthopedic impairments.
- • ASA 4 or 5 (American Society of Anesthesiologist Classification)
- • Neoadjuvant chemo- or radiation therapy
- • Renal failure III B or higher
- • Illiteracy or unable to write or understand Danish
- • Cognitive disabilities, which affects adherence e.g. severe dementia (MMSE score ≤17).
- • Withdrawal of consent.
About Zealand University Hospital
Zealand University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields to improve patient outcomes and enhance treatment methodologies. With a commitment to rigorous scientific standards and ethical practices, Zealand University Hospital collaborates with multidisciplinary teams to explore new therapies and interventions, contributing significantly to the global body of medical knowledge. Through its state-of-the-art facilities and focus on patient-centered care, the hospital plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Køge, Danmark, Denmark
Slagelse, Danmark, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials